AAM Welcomes US Access Bill

Bipartisan Legislation Would Exempt Low-Cost Drugs From Medicaid Penalty

The AAM has backed the draft Protecting Access to Affordable Medicines Act of 2020 introduced by the US House of Representatives members GK Butterfield, Billy Long and Tony Cardenas and has urged House members to co-sponsor the bill, which aims to protect low-cost generic medicines from a “misguided” Medicaid penalty.

Medical vials
The Act aims to help avoid shortages and improve access • Source: Shutterstock

The US Association for Accessible Medicines has applauded the introduction of the Protecting Access to Affordable Medicines Act of 2020 by the US House of Representatives members GK Butterfield, Billy Long and Tony Cardenas.

The Act aims to fix the currently imposed Medicaid generics penalty, which according to the AAM is “a misguided penalty...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Policy & Regulation

More from Generics Bulletin